INS and type 2 diabetes mellitus: Previous reports indicate that higher protein expression of GSK-3 (often elevated in patients with type 2 diabetes) is related to lower insulin action in skeletal muscle, whereas GSK-3 in adipose tissue is less likely to play a role in whole body glucose disposal [38].